Relay Therapeutics, Inc.
RLAY
$3.69
$0.288.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -70.38M | -77.07M | -76.00M | -88.11M | -92.21M |
| Total Depreciation and Amortization | 1.00M | 1.21M | 1.33M | 1.37M | 1.37M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.02M | 17.73M | 15.35M | 19.31M | 12.17M |
| Change in Net Operating Assets | -1.91M | -15.08M | 1.45M | -7.65M | 12.84M |
| Cash from Operations | -55.26M | -73.21M | -57.87M | -75.08M | -65.83M |
| Capital Expenditure | -26.00K | -384.00K | 0.00 | -227.00K | -11.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 75.17M | 42.85M | 29.00M | -125.94M | 45.56M |
| Cash from Investing | 75.15M | 42.47M | 29.00M | -126.16M | 45.55M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 653.00K | -- | 800.00K | 218.89M | 1.54M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 653.00K | -- | 800.00K | 218.89M | 1.54M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.54M | -30.75M | -28.07M | 17.64M | -18.74M |